Vitгіria | 3-flt

: Define FLT-3 and its shift from a purely leukemic marker to a target in solid tumor immunology.

: Tabulate existing FDA-approved inhibitors and their efficacy in solid vs. liquid tumors. VitГіria 3-FLT

: Describe how FLT-3 signaling drives hematopoietic cell proliferation and why mutations (like FLT3-ITD) lead to poor prognosis in acute myeloid leukemia (AML). : Define FLT-3 and its shift from a